Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Is Going Strong: Is the Market Following Fundamentals?
Option Care Health (NASDAQ:OPCH) has had a great run on the share market with its stock up by a significant 12% over the last week. Since the market usually pay for a company's long-term
Small Caps Have 'Incredible Tailwind' Coming: Portfolio Manager
Option Care Health Initiated at Market Outperform by JMP Securities
Option Care Health Initiated at Market Outperform by JMP
Option Care Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 18.42% JMP Securities → $36 Initiates Coverage On → Market Outperform 04/24/2024 25%
JMP Securities Initiates Option Care Health(OPCH.US) With Buy Rating, Announces Target Price $36
JMP Securities analyst Constantine Davides initiates coverage on $Option Care Health(OPCH.US)$ with a buy rating, and sets the target price at $36.According to TipRanks data, the analyst has a
Option Care Health (OPCH): A Strong Buy Amid Robust Growth and Expanding Market Share in Home Infusion Services
U.S. Intravenous Solutions (TPN, PPN) Market Size, Share & Trends Analysis Report 2024-2030 Featuring Fresenius Kabi, Pfizer, Baxter, ICU Medical, Option Care Health, and B. Braun Medical - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), and
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
Should You Investigate Option Care Health, Inc. (NASDAQ:OPCH) At US$27.34?
While Option Care Health, Inc. (NASDAQ:OPCH) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the NASDAQGS over the last few mont
United States Home Infusion Therapy Market Analysis 2024: A $19+ Billion Industry by 2032 Featuring Baxter, BD and Co, Eli Lilly & Co, Fresenius, ICU Medical, Option Care Health, & Terumo - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Home Infusion Therapy Market Report by Application, Product, States and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offeri
Did Option Care Health, Inc. (OPCH) Have a Solid Performance in Q1?
There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for feeling indifferent about Option Care Health, Inc.'s (NASDAQ:OPCH) P/E ratio of 17.8x.
Jefferies Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $38
Jefferies analyst Brian Tanquilut maintains $Option Care Health(OPCH.US)$ with a buy rating, and maintains the target price at $38.According to TipRanks data, the analyst has a success rate of 48.9% a
Option Care Health Insiders Added US$3.22m Of Stock To Their Holdings
In the last year, multiple insiders have substantially increased their holdings of Option Care Health, Inc. (NASDAQ:OPCH) stock, indicating that insiders' optimism about the company's prospects has in
Will Weakness in Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Prove Temporary Given Strong Fundamentals?
With 3.4% One-year Returns, Institutional Owners May Ignore Option Care Health, Inc.'s (NASDAQ:OPCH) 3.4% Stock Price Decline
Key Insights Given the large stake in the stock by institutions, Option Care Health's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 20 shareholder
Option Care Health Shareholders Back Leadership and Plans
Option Care Health to Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent national provider of home and alternate site infusion services, will
Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability
4 Stocks to Buy in a Thriving Outpatient Home Health Industry